UK markets closed
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • FTSE 250

    22,734.13
    +125.37 (+0.55%)
     
  • AIM

    1,249.65
    +3.03 (+0.24%)
     
  • GBP/EUR

    1.1648
    +0.0009 (+0.07%)
     
  • GBP/USD

    1.4117
    -0.0060 (-0.42%)
     
  • BTC-GBP

    24,815.90
    -309.25 (-1.23%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • DOW

    34,479.60
    +13.36 (+0.04%)
     
  • CRUDE OIL

    70.78
    +0.49 (+0.70%)
     
  • GOLD FUTURES

    1,879.50
    -16.90 (-0.89%)
     
  • NIKKEI 225

    28,948.73
    -9.83 (-0.03%)
     
  • HANG SENG

    28,842.13
    +103.25 (+0.36%)
     
  • DAX

    15,693.27
    +122.05 (+0.78%)
     
  • CAC 40

    6,600.66
    +54.17 (+0.83%)
     

Global Respiratory Diagnostics Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

·6-min read

Dublin, May 27, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global respiratory diagnostics market exhibited strong growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of around 7% during 2021-2026. Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth.

Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Product and Service Type:

  • Instruments and Services

  • Assays and Reagents

  • Services and Software

Market Breakup by Test Type:

  • Mechanical Tests

  • Obstructive Sleep Apnoea (OSA) Diagnostic Tests

  • Imaging Tests

  • Traditional Diagnostic Tests

  • Molecular Diagnostic Tests

  • Others

Market Breakup by Disease:

  • Tuberculosis

  • Asthma

  • Chronic Obstructive Pulmonary Disease (COPD)

  • Lung Cancer

  • Others

Market Breakup by End-User:

  • Hospitals

  • Clinics

  • Reference and Clinical Laboratories

  • Others

Market Breakup by Region:

  • North America

  • Europe

  • Asia Pacific

  • Middle East and Africa

  • Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific, Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics, COSMED, etc.

Key Questions Answered in This Report:

  • How has the global respiratory diagnostics market performed so far and how will it perform in the coming years?

  • What are the key regional markets in the global respiratory diagnostics industry?

  • What has been the impact of COVID-19 on the global respiratory diagnostics industry?

  • What is the breakup of the market based on the products and service type?

  • What is the breakup of the market based on the test type?

  • What is the breakup of the market based on the disease?

  • What is the breakup of the market based on the end-user?

  • What are the various stages in the value chain of the global respiratory diagnostics industry?

  • What are the key driving factors and challenges in the global respiratory diagnostics industry?

  • What is the structure of the global respiratory diagnostics industry and who are the key players?

  • What is the degree of competition in the global respiratory diagnostics industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product and Service Type
5.5 Market Breakup by Test Type
5.6 Market Breakup by Disease
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast

6 Market Breakup by Product and Service Type
6.1 Instruments and Services
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Assays and Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services and Software
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Test Type
7.1 Mechanical Tests
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Imaging Tests
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Traditional Diagnostic Tests
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Molecular Diagnostic Tests
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast

8 Market Breakup by Disease
8.1 Tuberculosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Asthma
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Chronic Obstructive Pulmonary Disease (COPD)
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Lung Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Reference and Clinical Laboratories
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Philips Healthcare
14.3.2 Abbott Laboratories
14.3.3 Biomerieux
14.3.4 Becton Dickinson
14.3.5 Thermo Fisher Scientific Inc.
14.3.6 Alere Inc.
14.3.7 Seegene Inc.
14.3.8 3M
14.3.9 Bio-Rad Laboratories Inc.
14.3.10 SDI Diagnostics
14.3.11 COSMED

For more information about this report visit https://www.researchandmarkets.com/r/t53m4d

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900